tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Shane Storey

Shane Storey

Wilsons
Wall Street Analyst
Ranked #2,725 out of 8,047 Analysts on TipRanks (#5,359 out of 21,521 overall experts)

Success Rate

63%
10 out of 16 Profitable Transactions

Average Return

12.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Shane Storey's ratings since 2022 and opened each position for the duration of 1 Year:
62.50% of your transactions would have been profitable with an average return of 12.9%

Stock Rating Distribution

40Ratings
72.50% Buy
27.50% Hold
0.00% Sell
Distribution of Shane Storey's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
AustraliaAustralian Market

Best Rating

Stock:
Telix Pharmaceuticals Ltd.
(TLPPF)
Rating Type:Buy
Dates:Jun 14, 2022 - Jan 01, 1970
Gain:101.40%
The most profitable rating made by Shane Storey

Shane Storey's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
OncoSil Medical Ltd
Mar 29, 2022
Buy
Reiterated
A$0.17
(188.14% Upside)
0.00%
1
Polynovo Limited
Apr 07, 2022
Hold
Reiterated
$0.79
(-43.50% Downside)
0.00%
1
Next Science Ltd
Apr 28, 2022
Buy
Reiterated
$1.28
(101.19% Upside)
100%
+8.80%
1
Impedimed Limited
Apr 28, 2022
Buy
Reiterated
$0.21
(225.91% Upside)
0%
0.00%
1
Ramsay Health Care
May 06, 2022
Hold
Reiterated
$57.94
(20.77% Upside)
0.00%
2
Cochlear Limited
May 18, 2022
Hold
Reiterated
$167.48
(11.19% Upside)
0.00%
1
Fisher & Paykel Healthcare Corporation Limited
May 26, 2022
Hold
Downgraded
$13.78
(-0.48% Downside)
0%
-26.10%
2
Hexima Ltd
Jun 01, 2022
Buy
Reiterated
A$0.75
(5669.23% Upside)
0.00%
1
Lumos Diagnostics Holdings Ltd.
Jul 12, 2022
Hold
Reiterated
A$0.50
(614.29% Upside)
0.00%
2
Pacific Smiles Group Ltd
Jul 15, 2022
Hold
Downgraded
A$1.92
(16.72% Upside)
0.00%
2
List of latest recommendations made by Shane Storey. Click to expand and see Shane Storey's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More